Table 4.
Multivariable Cox regression models predicting disease recurrence (any recurrence and bladder-only recurrence) in patients treated with radical nephroureterectomy for upper tract urothelial carcinoma
Any recurrence | Bladder-only recurrence | |||||
---|---|---|---|---|---|---|
| ||||||
Hazard ratio | 95% CI | p value | Hazard ratio | 95% CI | p value | |
Age, per 10 yr | 0.87 | 0.72–1.05 | 0.15 | 0.84 | 0.68–1.04 | 0.11 |
ASA | ||||||
<2 | Reference | Reference | Reference | Reference | ||
≥2 | 1.03 | 0.67–1.57 | 0.9 | 0.86 | 0.53–1.41 | 0.6 |
Pathologic stage | ||||||
≤pT1 | Reference | Reference | 0.002 | Reference | Reference | 0.6 |
pT2 | 1.45 | 0.82–2.56 | 1.39 | 0.75–2.57 | ||
≥pT3 | 2.31 | 1.44–3.70 | 1.06 | 0.58–1.93 | ||
Pathologic grade | ||||||
Low | Reference | Reference | Reference | Reference | ||
High | 1.39 | 0.74–2.62 | 0.3 | 1.27 | 0.67–2.42 | 0.5 |
Nodal status | ||||||
Not done | Reference | Reference | 0.3 | Reference | Reference | 0.04 |
Negative | 0.66 | 0.40–1.10 | 0.65 | 0.37–1.14 | ||
Positive | 0.80 | 0.40–1.63 | 0.25 | 0.08–0.74 | ||
Pathologic CIS | ||||||
No | Reference | Reference | Reference | Reference | ||
Yes | 1.00 | 0.64–1.57 | 0.99 | 0.93 | 0.55–1.57 | 0.8 |
Previous bladder cancer | ||||||
No | Reference | Reference | Reference | Reference | ||
Yes | 1.04 | 0.68–1.58 | 0.9 | 1.18 | 0.72–1.91 | 0.5 |
Surgical approach | ||||||
ORN | Reference | Reference | Reference | Reference | ||
LRN | 0.88 | 0.57–1.38 | 0.6 | 0.78 | 0.46–1.34 | 0.4 |
ASA = American Society of Anesthesiologists; CI= confidence interval; CIS = carcinoma in situ; LRN = laparoscopic radical nephroureterectomy; ORN = open radical nephroureterectomy.